
Lu Zhang
Articles
-
2 months ago |
advanced.onlinelibrary.wiley.com | Hongyue Tian |Hang Zhou |Lu Zhang |Wenjing Xu
Conflict of Interest The authors declare no conflict of interest. Supporting Information Filename Description adfm202422867-sup-0001-SuppMat.docx591.3 KB Supporting Information References 1, , , , , , , , , , , , , , , J. Am. Chem. Soc. 2024, 146, 12011. 2, , , , , , , , , , , , Adv. Mater. 2024, 36, 2400342. 3, , , , , , , , , , Nat. Energy. 2024, 9, 975. 4, , , , , , , , , Chem. Eng. J. 2023, 471, 144711. 5, , , , , , , , , , , , , , , , , , ACS Energy Lett. 2023, 8, 4104.
-
Jan 14, 2025 |
ajpmonline.org | Lu Zhang
Get full text accessLog in, subscribe or purchase for full access. REFERENCES1. Bailey, ZD ∙ Krieger, N ∙ Agénor, M ... Structural racism and health inequities in the USA: evidence and interventionsLancet (London, England). 2017; 389:1453-14632. Intrator, J ∙ Tannen, J ∙ Massey, DS. Segregation by race and income in the United States 1970-2010Social science research. 2016; 60:45-603. Larrabee Sonderlund, A ∙ Charifson, M ∙ Schoenthaler, A ...
-
Jan 10, 2025 |
onlinelibrary.wiley.com | Lu Zhang |Huan Shen |Tingting Liu |Xi Chen
Conflict of Interest The authors declare no conflict of interest. Supporting Information Filename Description smll202409836-sup-0001-SuppMat.docx3 MB Supporting Information References 1, , , , , , Nano Lett. 2018, 18, 7609. 2, , , , , , , , J. Nanobiotechnol. 2024, 22, 334. 3, , , , Adv. Healthcare Mater. 2022, 11, 2101971. 4, , , , , , , , , , Adv. Sci. 2024, 11, 2403935. 5, , , , , , Adv. Funct. Mater. 2024, 34, 2401893. 6, , , , , , , ACS Nano 2024, 18, 10063.
-
Jan 9, 2025 |
onlinelibrary.wiley.com | Ting Chen |Xueping Li |Yi Li |Lu Zhang
1 Introduction Hepatocellular carcinoma (HCC) ranks as the sixth most commonly diagnosed cancer and the third leading cause of cancer-related mortality worldwide.[1] Due to the insidious nature of HCC, most patients are often diagnosed at advanced stages and are only eligible to systemic treatments.[2] Despite the evolution of molecular-targeted therapy and immunotherapy has dramatically changed the systemic treatment landscape of advanced HCC, the overall response is still limited by the...
-
Dec 31, 2024 |
mdpi.com | Lu Zhang
This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessArticle by Shuyun Liu 1,2, Haifeng Zhao Prof. Dr. Haifeng Zhao is a professor at the School of Aeronautics and Astronautics, University of a [...] Prof. Dr. Haifeng Zhao is a professor at the School of Aeronautics and Astronautics, University of Chinese, Academy of Sciences and Technology and Engineering Center for Space Utilization, Chinese Academy of Sciences.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →